As mentioned earlier, the HSA‐TC‐Sulfo‐Cy5 conjugate prepared via the thiolation‐and‐conjugation approach not only did not alter the tumor targeting ability of HSA but also enhanced the uptake of HSA by cancer cells. The gene discussed is ALB; the disease is neoplasm.